Fielmann Group stock
Price history
−0.82% over the period1 year: from €42.85 (November 20, 2025) to €42.50 (November 20, 2026), −0.82%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | €42.50 |
| October 30, 2026 | €39.40 |
| September 30, 2026 | €38.55 |
| August 31, 2026 | €39.10 |
| July 31, 2026 | €40.65 |
| June 30, 2026 | €42.80 |
| May 29, 2026 | €44.70 |
| April 30, 2026 | €42.50 |
| March 31, 2026 | €43.55 |
| February 27, 2026 | €46.25 |
| January 30, 2026 | €41.40 |
| December 30, 2025 | €43.55 |
| November 28, 2025 | €43.85 |
| November 20, 2025 | €42.85 |
At a glance
The company
Manufacture and sell visual aids, eyewear, contact lenses, hearing systems and personal protective equipment through retail stores and digital channels
Latest results
Quarter to June 30, 2026 · EPS €0.67
TickerLandia's take on Fielmann Group
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 18 vs a median of 32 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 16 vs 25 (−35%) in a group of 9.
- Strong point: Earnings stability (71/100 in its group). Weak point: Financial strength (38/100).
- “Below historical valuation” (Germany): No. 4 of 20.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−11.37% from the 52-week high
Analysts · 9 analysts
Average target€54.88+29.12% vs. price
Buy 7 · Hold 2 · Sell 0 · Buy
TickerLandia Fingerprint: Fielmann Group
Compared with similar companies: very low price.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricevery low18
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 16.4 2 Price/book 3.23 46 Forward P/E 15.6 25 EV/EBITDA 9.31 1 Price/sales 1.44 16 Profitabilityhigh67
How much it earns on revenue and capital.
Metric Value Position in group Net margin 8.5% 54 ROE 20.1% 72 ROA 8.4% 66 Gross margin 80.3% 96 Operating margin 13.7% 46 Earnings stabilityhigh71
How steady its margins were over the last five annual reports.
Metric Value Position in group Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Margin variabilitycounts in reverse: lower means more earnings stability 1.7% 78 Growthaverage50
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +11.45% 84 Revenue growth (year over year) +4.70% 38 Earnings growth (year over year) +11.30% 29 Financial strengthlow38
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 7.54 55 Debt/equitycounts in reverse: lower means more financial strength 0.81 26 Current ratio 1.35 34 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.52 36 Dividendhigh60
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 6 years 19 Payout ratio 53.8% 69 Dividend yield 3.3% 93 Market momentumaverage52
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −0.82% 35 Relative strength (3 months) +6.51% 68 Relative strength (6 months) −4.21% 47 Distance from 200-day average +1.50% 58 Risklow28
How much the price swings.
Metric Value Position in group Volatility (60 days) 19.8% 18 Beta (1 year) 0.43 22 Maximum drawdown (12 months) 22.9% 44
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Fielmann Group is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Fielmann Group's P/E today is 17.5, below the median of its last 10 fiscal years (32.2; between 17.9 and 47.9 from 2016 to 2025). Fielmann Group's P/E (trailing 12 months): 16.4, −35% against the median of a group of 9 similar companies (25.1).
Compared with 9 similar companies
| Metric | Fielmann Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 16.4 | Low | |
| Forward P/E | 15.6 | Middle | |
| Operating margin | 13.7% | Middle | |
| ROE | 20.1% | Middle | |
| Debt/equity | 0.81 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Fielmann Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€634.9M
Latest quarter · Q2 2026
Net income
€55.81M
Latest quarter · Q2 2026
Quarterly net margin
8.8%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €3.58B
- P/E
- 16.4
- EPS
- €2.60
- Volume
- 8.63K
- Daily trading
- €2.36M
- Dividend yield
- 3.29%
- Last ex-dividend on July 10, 2026
How Fielmann Group is changing
All resultsRevenue grew 11.3% a year on average over the last 5 years
Operating margin rose from 9.2% to 13.5%
Profits turn into cash: free cash flow equal to 190% of net income
Returns
Fielmann Group returns with dividends
€1,000 invested in Fielmann Group 5 years ago, on November 22, 2021, would be worth €778 today with dividends reinvested: −22.22% in total, −4.91% per year. On price alone it would be €684 (−31.62%).
| Period | Fielmann Group | DAX | €1,000 becomes |
|---|---|---|---|
| 1 month | +9.54% | −1.98% | €1,095 |
| 6 months | −3.95% | +0.26% | €960 |
| Year to date | −2.41% | +1.28% | €976 |
| 1 year | +2.59% | +6.55% | €1,026 |
| 3 years | −0.49% | +55.98% | €995 |
| 5 years | −22.22% | +53.90% | €778 |
| 10 years | −11.12% | +132.12% | €889 |
Over the last 6 months it has done better than 17% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment
The chart in detail
Fielmann Group: technical analysis
Fielmann Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 45.1% below its all-time closing high (€77.47, October 26, 2017).
- Trend
- No clear trend
- RSI (14 sessions)
- 59
- Between 30 and 70
- vs 200-session average
- +1.50%
Support and resistance
Price areas where Fielmann Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€45.13+6.20%3 touches, last on May 29, 2026
- Resistance€44.28+4.18%4 touches, last on November 5, 2026
- Last price€42.50
- Support€42.08−1.00%8 touches, last on August 20, 2026
- Support€40.92−3.73%3 touches, last on June 8, 2026
- Support€39.67−6.65%2 touches, last on September 8, 2026
Volatility and risk
Over the last year it has moved less than the DAX.
- Beta (1 year) vs DAX
- 0.43
- Volatility (60 sessions, annualised)
- 19.8%
- Largest fall in the last year
- −22.88%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Fielmann Group: seasonality
Average monthly price change over 31 years
Over the last 31 years, the strongest month for Fielmann Group has been April: +3.70% on average, positive in 18 years out of 31. The weakest has been July: −2.30% on average, positive in 10 years out of 31. November, the current month, has been positive in 18 years out of 30 (+0.19% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.68% | +2.34% | 16 of 30 |
| February | −0.22% | −2.63% | 14 of 31 |
| March | −0.16% | −0.18% | 15 of 31 |
| April | +3.70% | +1.53% | 18 of 31 |
| May | +3.65% | +4.08% | 24 of 31 |
| June | −0.47% | +0.21% | 16 of 31 |
| July | −2.30% | −2.21% | 10 of 31 |
| August | +0.89% | +0.88% | 17 of 31 |
| September | −1.01% | −0.47% | 13 of 31 |
| October | +1.02% | +2.04% | 19 of 31 |
| November | +0.19% | +1.32% | 18 of 30 |
| December | +1.17% | +0.85% | 17 of 30 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Fielmann Group and its competitors
Sales of Fielmann Group AG reach customers in Germany, Switzerland, Austria, Spain and North America, as well as in other markets abroad. The group works in vision care and audiology, designing and selling vision aids such as spectacles, lenses and contact lenses, hearing systems and protective equipment. Its products are sold under several brands, including fielmann and Optika Clarus, through retail stores, digital channels and the Befitting online optical platform. The company was renamed Fielmann Group AG in July 2023, having been founded in 1972.
- Headquarters
- Hamburg, Germany
- Employees
- 18,213
- Founded
- 1972
- Chief executive
- Marc Fielmann
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Fielmann GroupFIE | $3.93B | 13.7% | 16.4 | −3.95% |
| SCHOTT Pharma1SXP | $3.74B | 16.4% | 25.1 | +34.04% |
| Tecan GroupTECN | $3.58B | 4.9% | — | +64.44% |
| Carl Zeiss MeditecAFX | $3.07B | 7.2% | 23.3 | +24.32% |
| OttobockOBCK | $2.68B | 18.7% | 19.0 | −31.33% |
| ConvaTec GroupCTEC | $6.66B | 16.3% | 53.2 | +24.09% |
Same industry or related industries, similar size. Compare Fielmann Group with its competitors · Full profile
